Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Trial Profile

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 May 2018

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
  • Indications Acute coronary syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms UPSTREAM
  • Sponsors AstraZeneca
  • Most Recent Events

    • 21 May 2018 Planned End Date changed from 30 Mar 2018 to 31 Mar 2020.
    • 21 May 2018 Planned primary completion date changed from 30 Mar 2018 to 31 Mar 2020.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top